Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v8-EN Version v3-EN
Language English English
Date Updated 2023-06-14 2023-05-13
Drug Identification Number 02322765 02322765
Brand name GRANISETRON HYDROCHLORIDE INJECTION GRANISETRON HYDROCHLORIDE INJECTION
Common or Proper name GRANISETRON HYDROCHLORIDE INJECTION GRANISETRON HYDROCHLORIDE INJECTION
Company Name OMEGA LABORATORIES LIMITED OMEGA LABORATORIES LIMITED
Ingredients GRANISETRON GRANISETRON
Strength(s) 1MG 1MG
Dosage form(s) LIQUID LIQUID
Route of administration INTRAVENOUS INTRAVENOUS INTRAVENOUS INTRAVENOUS
Packaging size 10 x 1mL vial / fiole 10 x 1mL vial / fiole
ATC code A04AA A04AA
ATC description ANTIEMETICS AND ANTINAUSEANTS ANTIEMETICS AND ANTINAUSEANTS
Reason for shortage Demand increase for the drug. Demand increase for the drug.
Anticipated start date
Actual start date 2023-05-12 2023-05-12
Estimated end date 2023-06-02
Actual end date 2023-06-13
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments product not available at Omega warehouse; product available at CPDN.
Health Canada comments